Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Ketorich - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Ketorich

Approved

STANDARD

Ketorich

4CARE LIFESCIENCE PRIVATE LTD.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: d862f2582a49b8f1
Company: 4CARE LIFESCIENCE PRIVATE LTD.
Type: Standard

Approval Details

Approval Id: d862f2582a49b8f1
Drug Approval Philippines Name: Ketorich
Product Name: Ketorich
Registration Number: DRP-14171-03
Brand Name: Ketorich
Generic Name: Ketoanalogues + Essential Amino Acids
Dosage Form: Film-Coated Tablet
Dosage Strength: (see reverse for formulation)
Manufacturer: 4CARE LIFESCIENCE PRIVATE LTD.
Importer: AGLOBAL CARE, INC
Distributor: MEDIRICH PHARMA DISTRIBUTION CORP
Issuance Date: 24 March 2024
Expiry Date: 14 July 2028
Pharmacologic Category: Renal Nutritional Therapy
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

d862f2582a49b8f1

Type

Standard

Back to Philippines FDA Approvals